Our results and that of Parikh et al suggest that the risk effects observed in the PSA locus may reflect the increased identification of men with clinically insignificant and non-life threatening prostate cancers by the use of PSA for screening of prostate cancer. This evidence concerns the gene KLK3 and prostate carcinoma.